Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on July 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

DEXTROSE INJECTION,

Closed
SPE2DP-26-T-4124Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract solicits DEXTROSE 5% INJECTION, USP, 100 ML, packaged in units of 80 (1 PG = 80 EA), under NSN 6505-01-384-1362, with BAXTER HEALTHCARE as the referenced manufacturer and NDC 00338-0551-18. This is a regulated pharmaceutical product subject to FDA oversight, and the acquisition is governed by strict technical and quality standards incorporated from the DLA Master List of Technical and Quality Requirements, including RP001 for packaging, RA001 for technical specifications, RQ011 requiring removal of government identification from non-accepted supplies, and RS016 mandating a non-extendable 24-month shelf life for this TYPE I (CODE M) item. Packaging must conform to commercial standards, with each unit sealed to prevent damage and shipped in externally suitable containers meeting Medical Marking Standard No. 1, which replaces MIL-STD-129; preservation and labeling must also comply with MIL-STD-2073-1E and Special Packaging Instructions MPWNN00001 dated 03/30/1988. Delivery is required within five days after order placement, FOB destination, to locations including Fort Carson, CO, and Fort Bragg, NC, with no variance permitted in quantity. Items must be shipped by the fastest traceable means, prohibiting parcel post. All vendors must be registered in SAM, provide CAGE codes, and submit required representations regarding small business status, socioeconomic programs, and covered telecommunications. The contract prohibits the use of additive manufacturing for this item unless explicitly authorized after an Engineering Support Activity review. Compliance with the Berry Amendment and Buy American Act is mandatory, and contractors must adhere to NIST SP 800-171 cybersecurity requirements, FAR 52.223-3 for hazardous material identification, and DFARS 252.204-7016 regarding covered defense telecommunications. Invoicing and payment must be processed exclusively through WAWF, requiring electronic submission of both invoices and receiving reports for fixed-price items. Offers must align with the latest FAR clauses, including deviations for System for Award Management maintenance, contract type, simplified acquisition terms, and small business representation all updated under Deviation 2026-00038, and must be

General Info

Dextrose 5% Injection, 100 mL, 80 units per package, FOB destination, 24-month shelf life, DLA-compliant packaging, Baxter Healthcare.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

BLDG 7465 BAD TOELZ RD, FORT CARSON, CO, 80913-4093, USA

Set-Aside

NONE

Documents

1
PDF, High priority: read this firstrfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

2 updates
PhaseClosed
Posted

Solicitation

Notice updated

The notice description changed.

Notice updated

The notice description changed.

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
DEXTROSE INJECTION,
DEXTROSE 5% INJECTION, USP, 100 ML, 80S
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
BAXTER HEALTHCARE NDC 00338-0551-18
U/I PACKAGE OF 80
95037 MABG JARVIS
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 PG = 80 EA
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a
SPE2DP-26-T-4124
SECTION B
shelf life of 24 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
BAXTER HEALTHCARE CORP IV 04687 P/N 2B0041 BAXTER HEALTHCARE CORPORATION 1G026 P/N NDC00338-0551-18
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017480614 0001 PG 1.000
NSN/MATERIAL:6505013841362
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-384-1362 Quantity: 1 PG Purchase Request: 7017480615QTY: 1 Delivery: 5 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATION
Solicitation # SPE2DP-27-T-0210
Solicitation SPE2DP-27-T-0210 is a small business set-aside request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of sunscreen preparation, identified by NSN 6505016579247. The required product is an over-the-counter topical sunscreen with an SPF of 50, containing 4.5% titanium dioxide and 4% zinc oxide. It must be hypoallergenic, oil-free, PABA-free, biodegradable, and sweat and water-resistant for 80 minutes. The unit of issue is a package containing 24 three-ounce tubes. The product has a total shelf life of 24 months, with a minimum of 21 months remaining upon receipt by the government. Storage requirements specify a cool, dry place between 15 and 30 degrees Celsius. The contract specifies a delivery period of 20 days after receipt of order, with an original required delivery date of November 3, 2026. Delivery is FOB Destination to the USNS Henson. Packaging must be commercial and adhere to DLA packaging requirements, with medical marking following Medical Marking Standard No. 1. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025; otherwise, it should follow ASTM D3951. Invoicing and payment will be processed electronically through the Wide Area WorkFlow system. The solicitation incorporates various FAR and DFARS clauses, including the Buy American Act, safeguarding of covered defense information, and specific restrictions on covered defense telecommunications equipment. Quotations are due by November 9, 2026.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 20 hours ago

DEADLINE

in 7 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS